DK0879603T3 - Calciumkanalantagonist med hæmmende virkning på frigivelse af parathyroidhormoner samt anvendelse af denne - Google Patents

Calciumkanalantagonist med hæmmende virkning på frigivelse af parathyroidhormoner samt anvendelse af denne

Info

Publication number
DK0879603T3
DK0879603T3 DK98109216T DK98109216T DK0879603T3 DK 0879603 T3 DK0879603 T3 DK 0879603T3 DK 98109216 T DK98109216 T DK 98109216T DK 98109216 T DK98109216 T DK 98109216T DK 0879603 T3 DK0879603 T3 DK 0879603T3
Authority
DK
Denmark
Prior art keywords
channel antagonist
calcium channel
calcium
release
parathyroid hormones
Prior art date
Application number
DK98109216T
Other languages
Danish (da)
English (en)
Inventor
Ranko Inoue
Takeshi Inoue
Takuo Fujita
Yoshihisa Kudoh
Seiichi Yamagiwa
Original Assignee
Fujix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujix Inc filed Critical Fujix Inc
Application granted granted Critical
Publication of DK0879603T3 publication Critical patent/DK0879603T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98109216T 1997-05-21 1998-05-20 Calciumkanalantagonist med hæmmende virkning på frigivelse af parathyroidhormoner samt anvendelse af denne DK0879603T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13090797 1997-05-21

Publications (1)

Publication Number Publication Date
DK0879603T3 true DK0879603T3 (da) 2004-03-08

Family

ID=15045527

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98109216T DK0879603T3 (da) 1997-05-21 1998-05-20 Calciumkanalantagonist med hæmmende virkning på frigivelse af parathyroidhormoner samt anvendelse af denne

Country Status (12)

Country Link
US (2) US6190665B1 (fr)
EP (1) EP0879603B1 (fr)
KR (1) KR19980087260A (fr)
CN (1) CN1140270C (fr)
AT (1) ATE256471T1 (fr)
AU (1) AU751445B2 (fr)
CA (1) CA2235430C (fr)
DE (1) DE69820527T2 (fr)
DK (1) DK0879603T3 (fr)
ES (1) ES2213238T3 (fr)
PT (1) PT879603E (fr)
TW (1) TWI227670B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI227670B (en) * 1997-05-21 2005-02-11 Fujix Inc A process for the preparation of a calcium antagonist
CN1739390A (zh) * 2004-08-27 2006-03-01 株式会社日本生物科学研究所 矿物质制剂和其原料及其制造方法
US10489826B2 (en) * 2016-12-27 2019-11-26 Rovi Guides, Inc. Systems and methods for submitting user selected profile information to an advertiser

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2525484B2 (ja) * 1989-08-30 1996-08-21 森下仁丹株式会社 骨粗鬆症治療剤
JP2702322B2 (ja) * 1991-08-08 1998-01-21 フジックス株式会社 活性アミノ酸カルシウム、およびそれを含有する飲料、ならびにその製造方法
JPH05161480A (ja) * 1991-10-14 1993-06-29 Fujitsukusu Kk アミノ酸を配合したカルシウム組成物およびそれを含有するカルシウム飲料
JPH05262655A (ja) * 1992-03-07 1993-10-12 Fujitsukusu Kk カルシウムの腸管吸収促進剤および腸管吸収性を高め たカルシウム組成物ならびにそれを含有するカルシウ ム飲料
JP2923181B2 (ja) * 1993-09-20 1999-07-26 フジックス株式会社 高濃度のカルシウムを含有する水溶性粉末およびその製造方法
FR2712810B1 (fr) * 1993-11-22 1996-01-19 Texinfine Sa Compositions à base d'algues du type padina pavonica ou de leurs extraits destinées à améliorer la fixation du calcium par les tissus biologiques, leurs utilisations.
TWI227670B (en) * 1997-05-21 2005-02-11 Fujix Inc A process for the preparation of a calcium antagonist

Also Published As

Publication number Publication date
CN1140270C (zh) 2004-03-03
EP0879603A1 (fr) 1998-11-25
EP0879603B1 (fr) 2003-12-17
TWI227670B (en) 2005-02-11
CN1207320A (zh) 1999-02-10
US20010000473A1 (en) 2001-04-26
US6190665B1 (en) 2001-02-20
ES2213238T3 (es) 2004-08-16
US6475532B2 (en) 2002-11-05
DE69820527D1 (de) 2004-01-29
ATE256471T1 (de) 2004-01-15
AU6799298A (en) 1998-11-26
DE69820527T2 (de) 2004-10-14
CA2235430A1 (fr) 1998-11-21
AU751445B2 (en) 2002-08-15
PT879603E (pt) 2004-04-30
KR19980087260A (ko) 1998-12-05
CA2235430C (fr) 2006-07-25

Similar Documents

Publication Publication Date Title
IE823046L (en) Stabilised interferon formulations
AU2982889A (en) Novel dosage form of fenofibrate
NZ515392A (en) Respiratory syncytial virus replication inhibitors
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO166367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
HU9601251D0 (en) Process for the preparation of concentrated, biologically active silicon compounds
DK0879603T3 (da) Calciumkanalantagonist med hæmmende virkning på frigivelse af parathyroidhormoner samt anvendelse af denne
WO2002024164A3 (fr) Procede de granulation par extrusion basse pression
NO803245L (no) Fremgangsmaate ved fremstilling av cyclisk hexapeptid somatostatinanaloger.
JPS5299289A (en) Preparation of l-arginine by fermentation
EP0970115A4 (fr) Peptides viraux presentant une homologie structurelle avec la proteine g du virus respiratoire syncytial bovin
AU3258097A (en) Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process
DE60114668D1 (de) Prozess zur Herstellung des Anti-Migräne Wirkstoffs Eletriptan
JPS5399314A (en) Therapeutic agent for nephritis
ES481109A1 (es) Un metodo de preparacion de un extracto de stephania cepha- rantha.
JPS53127808A (en) Preparation of human albumin
JPS5247980A (en) Method of preparing new nuclease
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation
JPS5398965A (en) Preparation of 1,3-dimethyl-2-imidazolidinone
JPS53119463A (en) Drying system
JPS5428893A (en) Preparation of sarcosine oxidase
JPS5338617A (en) Preparation of hepatitis-b vaccine
JPS53113020A (en) Controlling agents against plant pests caused by virus
IT1123488B (it) Corpo ceramico per cromatografia,e procedimento per la sua preparazione
JPS5414905A (en) Preparation of phytone or isophytol